Lotte Biologics to Invest US$48 mln in U.S. Plant

SEOUL, April 18 (Korea Bizwire) — Lotte Biologics Co., a pharmaceutical unit under the South Korean retail giant Lotte Group, said Tuesday it will invest US$48 million into its recently acquired U.S. plant to upgrade and boost its production capacity. The Korean company purchased the factory from global biopharmaceutical company Bristol Myers Squibb in Syracuse, [...]